Ratings by Brookline Capital Markets (Sally Yanchus)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/11/2020 DermTech Inc. DMTK New Coverage Buy
(N/A)
10.65
(41.26)
287.42% Details
8/17/2020 9 Meter Biopharma NMTR New Coverage Buy
(N/A)
0.57
(1.43)
150.88% Details
7/15/2020 Antibe Therapeutics ATBPF New Coverage Buy
(N/A)
0.28
(3.08)
1000% Details
6/18/2020 Lexagene Holdings LXXGF New Coverage Buy
(N/A)
0.57
(0.62)
8.77% Details
6/3/2020 Assertio Therapeutics ASRT New Coverage Buy
(N/A)
1.00
(1.72)
72% Details
5/14/2020 Biocept BIOC New Coverage Buy
(N/A)
0.44
(4.40)
900% Details
4/28/2020 Dare Bioscience DARE New Coverage Buy
(N/A)
1.04
(1.33)
27.88% Details
4/14/2020 Bellerophon Therapeutics BLPH New Coverage Buy
(N/A)
11.42
(4.63)
-59.46% Details
2/5/2020 BIOX New Coverage Buy
(N/A)
4.95
(12.00)
142.42% Details